Strategic Partner A/S proposes a new board for CombiGene, nominating Luca Di Stefano as chairman and introducing Jakob Bendtsen and Lars Thunberg. The company remains focused on gene therapy and advanced treatments for severe diseases.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.